Peer-influenced content. Sources you trust. No registration required. This is HCN.
Johns Hopkins Medicine
Johns Hopkins psychiatrists are spearheading a novel educational initiative, ADAP Jr. High, to address the critical gap in middle schoolers’ understanding of anxiety and depression, offering structured lessons and coping strategies to empower young students.
Family Medicine/General Practice March 12th 2024
A recent study underscores the delicate balance required in thyroid hormone therapy for older adults, highlighting a clear association between thyrotoxicosis and heightened cognitive disorder risk.
Clinical Pharmacology March 12th 2024
The Johns Hopkins Clozapine Consultation Clinic is addressing the critical underutilization of clozapine in treatment-resistant schizophrenia, providing essential support and education for healthcare providers in navigating its benefits and risks.
Neurology March 12th 2024
Dana-Farber Cancer Institute
Under Dr. Laurie Glimcher’s leadership, Dana-Farber Cancer Institute is embarking on a transformative journey with the creation of a new, dedicated cancer hospital, promising a future of specialized care and improved patient experiences in oncology.
Hematology/Oncology March 11th 2024
Explore the transformative potential of antibody-drug conjugates (ADCs) in cancer therapy, offering targeted treatments with reduced side effects. Recent approvals and ongoing trials signify a significant shift towards precision medicine in oncology.
Oncology, Medical March 4th 2024
UCSF MedConnection
Explore the potential of IS-002, an imaging agent that offers a new dimension in intraoperative prostate cancer detection, promising a more targeted approach to surgical intervention and patient management.